Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertus Eksteen

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Clinics in Liver Disease|November 24, 2015
The Gut-Liver Axis in Primary Sclerosing CholangitisBertus Eksteen
Hepatology (Baltimore, Md.)|December 7, 2015
Predicting risk in primary biliary cholangitisBertus Eksteen
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|March 22, 2013
Monitoring hepatitis C infection in the liver allograftBertus Eksteen
Digestive Diseases (Basel, Switzerland)|July 8, 2011
Infections and the liverBertus Eksteen
British Medical Bulletin|May 6, 2014
Advances and controversies in the pathogenesis and management of primary sclerosing cholangitisBertus Eksteen
Gut|June 21, 2014
Targeting of gut specific leucocyte recruitment in IBD by vedolizumabBertus Eksteen
Nature Reviews. Immunology|February 25, 2006
Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel diseaseDavid H Adams, Bertus Eksteen
Idrugs : the Investigational Drugs Journal|June 29, 2010
GSK-1605786, a selective small-molecule antagonist of the CCR9 chemokine receptor for the treatment of Crohn's diseaseBertus Eksteen, David H Adams
Biologics : Targets & Therapy|March 30, 2016
Selective biologics for ulcerative colitis and Crohn's disease - clinical utility of vedolizumabJill Mv Petkau, Bertus Eksteen
Nature Clinical Practice. Gastroenterology & Hepatology|March 5, 2008
Mechanisms of disease: the evolving understanding of liver allograft rejectionBertus Eksteen, James M Neuberger
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Clinics in Liver Disease|November 24, 2015
The Gut-Liver Axis in Primary Sclerosing CholangitisBertus Eksteen
Hepatology (Baltimore, Md.)|December 7, 2015
Predicting risk in primary biliary cholangitisBertus Eksteen
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|March 22, 2013
Monitoring hepatitis C infection in the liver allograftBertus Eksteen
Digestive Diseases (Basel, Switzerland)|July 8, 2011
Infections and the liverBertus Eksteen
British Medical Bulletin|May 6, 2014
Advances and controversies in the pathogenesis and management of primary sclerosing cholangitisBertus Eksteen
Gut|June 21, 2014
Targeting of gut specific leucocyte recruitment in IBD by vedolizumabBertus Eksteen
Nature Reviews. Immunology|February 25, 2006
Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel diseaseDavid H Adams, Bertus Eksteen
Idrugs : the Investigational Drugs Journal|June 29, 2010
GSK-1605786, a selective small-molecule antagonist of the CCR9 chemokine receptor for the treatment of Crohn's diseaseBertus Eksteen, David H Adams
Biologics : Targets & Therapy|March 30, 2016
Selective biologics for ulcerative colitis and Crohn's disease - clinical utility of vedolizumabJill Mv Petkau, Bertus Eksteen
Nature Clinical Practice. Gastroenterology & Hepatology|March 5, 2008
Mechanisms of disease: the evolving understanding of liver allograft rejectionBertus Eksteen, James M Neuberger
Pageof 8